Diabetes: Treating diabetic nephropathy-still an unresolved issue

Research output: Contribution to journalReview ArticleOtherpeer-review

Abstract

Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes. 

Original languageEnglish
Pages (from-to)515-516
Number of pages2
JournalNature Reviews Endocrinology
Volume8
Issue number9
DOIs
Publication statusPublished - Sep 2012
Externally publishedYes

Cite this

@article{defc23e0a0fb47a28cb9f5daacc912c1,
title = "Diabetes: Treating diabetic nephropathy-still an unresolved issue",
abstract = "Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes. ",
author = "Cooper, {Mark E.}",
year = "2012",
month = "9",
doi = "10.1038/nrendo.2012.125",
language = "English",
volume = "8",
pages = "515--516",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "Nature Publishing Group",
number = "9",

}

Diabetes : Treating diabetic nephropathy-still an unresolved issue. / Cooper, Mark E.

In: Nature Reviews Endocrinology, Vol. 8, No. 9, 09.2012, p. 515-516.

Research output: Contribution to journalReview ArticleOtherpeer-review

TY - JOUR

T1 - Diabetes

T2 - Treating diabetic nephropathy-still an unresolved issue

AU - Cooper, Mark E.

PY - 2012/9

Y1 - 2012/9

N2 - Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes. 

AB - Whether treatment of hyperglycaemia prevents progression of diabetic nephropathy is controversial. Intensive glycaemic control reduces the risk of microalbuminuria and macroalbuminuria, but there is no clear-cut evidence showing that it reduces doubling of serum creatinine levels or risk of death from kidney disease. Larger studies or further follow-up of previous trials are required to better assess renal outcomes. 

UR - http://www.scopus.com/inward/record.url?scp=84865223234&partnerID=8YFLogxK

U2 - 10.1038/nrendo.2012.125

DO - 10.1038/nrendo.2012.125

M3 - Review Article

VL - 8

SP - 515

EP - 516

JO - Nature Reviews Endocrinology

JF - Nature Reviews Endocrinology

SN - 1759-5029

IS - 9

ER -